Market Closed -
Japan Exchange
02:00:00 2024-05-02 am EDT
5-day change
1st Jan Change
1,839
JPY
+0.05%
+0.60%
+3.31%
KYORIN Holdings, Inc.'s Equity Buyback announced on September 26, 2018 has expired with 16,574,000 shares for ¥40,838.34 million. The company repurchased 14,328,000 shares, representing 19.18% of the outstanding shares, for ¥35,300 million from Teijin Limited.
The company expired its plan on September 27, 2018.
ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan
23-02-06
MT
KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500
21-12-20
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020
20-02-04
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Fiscal Year 2020 Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019, Payable on December 3, 2019; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2020
19-11-06
CI
KYORIN Holdings, Inc.(TSE:4569) dropped from FTSE All-World Index
19-09-23
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2020 and Year Ending March 31, 2020
19-07-30
CI
Tranche Update on KYORIN Holdings, Inc.'s Equity Buyback Plan announced on September 26, 2018.
18-09-26
CI
KYORIN Holdings, Inc.'s Equity Buyback announced on September 26, 2018 has expired with 16,574,000 shares for ¥40,838.34 million. The company repurchased 14,328,000 shares, representing 19.18% of the outstanding shares, for ¥35,300 million from Teijin Limited.
18-09-26
CI
KYORIN Holdings, Inc. announces an Equity Buyback for 18,000,000 shares, representing 24.09% for ¥44,352 million.
18-09-26
CI
KYORIN Holdings, Inc. authorizes a Buyback Plan.
18-09-25
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2018; Provides Earnings for the First Half and Full Year of Fiscal Year Ending March 31, 2019
18-05-09
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2018
18-02-04
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018; Announces Dividend for the Second Quarter Ended September 30, 2017, Payable on December 4,2017; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2018
17-11-05
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2018 and Year Ending March 31, 2018; Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018
17-07-30
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2017; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2018
17-05-10
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Dividend Guidance for the Year Ending March 31, 2017; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017
17-02-02
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Announces Dividend Second Quarter Ended September 30, 2016, Payable December 5, 2016 and Provides Dividend Guidance for the Year Ending March 31, 2017; Provides Earnings Guidance for the Year Ending March 31, 2017
16-11-06
CI
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016
16-07-28
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Year Ended March 31, 2016; Provides Consolidated Earnings Guidance for the First Half of the Year Ending March 31, 2017 and Full Year Ending March 31, 2017
16-05-11
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2015; Provides Earnings Guidance for the Year Ending March 31, 2016; Provides Year End Dividend Guidance for the Year Ending March 31, 2016
16-02-02
CI
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2015; Announces Dividend for the Second Quarter of Fiscal 2016, Payable on December 4, 2015; Revises Dividend for the Year End Ending March 31, 2016; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016
15-11-04
CI
Kyorin Holdings, Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Dividend Guidance for Second Quarter and Full Year of Fiscal Year Ending March 31, 2016; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016
15-08-01
CI
Kyorin Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Earnings Forecast for the Six Months and Full Year of Fiscal 2016; Announces Dividend for the Year End of Fiscal Year 2015, Payable on June 9, 2015; Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year 2016
15-05-12
CI
Kyorin Holdings, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015; Provides Year End Dividend Guidance for the Year Ending March 31, 2015
15-02-01
CI
KYORIN Holdings, Inc. Reports Consolidated Financial Results for the Six Months Ended September 30, 2014; Provides Earnings and Dividend Guidance for the Full Year Ending March 31, 2015; Announces Dividend for the Second Quarter Ended September 30, 2014, Payable on December 5, 2014
14-11-06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
More about the company
Mean consensus
UNDERPERFORM
Last Close Price
1,839
JPY
Average target price
1,500
JPY
Spread / Average Target
-18.43%
Consensus
1st Jan change
Capi.
+3.31% 691M +26.08% 662B +22.15% 546B -4.77% 359B +16.97% 323B +5.69% 289B +13.68% 234B +4.17% 198B -10.96% 194B +8.08% 167B
Other Pharmaceuticals
Stock Market Equities 4569 Stock
News KYORIN Pharmaceutical Co., Ltd. KYORIN Holdings, Inc.'s Equity Buyback announced on September 26, 2018 has expired with 16,574,000 shares for ¥40,838.34 million. The company repurchased 14,328,000 shares, representing 19.18% of the outstanding shares, for ¥35,300 million from Teijin Limited.
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1